Effects of Bevespi on Ventilation and Gas Exchange Abnormalities in COPD Assessed by 129Xe MRI

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

April 20, 2018

Primary Completion Date

November 12, 2019

Study Completion Date

November 12, 2019

Conditions
COPD
Interventions
DRUG

hyperpolarized 129Xe gas MRI

There will be MRI imaging before the treatment with Bevespi and another one 2 weeks after use Bevespi. Images obtained using 129Xe MRI will be compared with standard lung function tests that are used routinely in the clinic, 6 minute walk test that assesses walking ability and several questionnaires that assess shortness of breath and life quality.

DRUG

Bevespi Aerosphere

There will be MRI imaging before the treatment with Bevespi and another one 2 weeks after use Bevespi.

Trial Locations (1)

27705

Duke Asthma, Allergy, and Airway Center, Durham

All Listed Sponsors
lead

Bastiaan Driehuys

OTHER

NCT03324607 - Effects of Bevespi on Ventilation and Gas Exchange Abnormalities in COPD Assessed by 129Xe MRI | Biotech Hunter | Biotech Hunter